2014
DOI: 10.1016/j.idairyj.2014.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Determination of myo-inositol in infant formulae and milk powders using capillary gas chromatography with flame ionisation detection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 29 publications
1
6
0
Order By: Relevance
“…The galactose content was higher than those found by Morales et al (2004) and similar to those obtained by Troyano, Villamiel, Olano, Sanz, and Martinez-Castro (1996) in commercial sterilized milks. Myo-inositol, a polyalcohol that may play a significant role in the prevention of bronchopulmonary dysplasia and retinopathy in premature infants (Hallman, Saugstad, Porreco, Epstein, & Gluck, 1985), was present in all IFs at concentrations significantly higher than those reported for Spanish commercial milks (Troyano et al, 1996), but similar to the found by Woollard, Macfadzean, Indyk, McMahon, and Christiansen (2014). As expected, with the exception of the lactose-free IFs, lactose was the main carbohydrate in all studied products, with amounts varying between 19.2 and 70.1 g/100 g. Maltose was found in most of the analysed IFs in a range from 0.2 to 7 g/100 g. This compound is usually not added as ingredient in IFs and its presence may be related to the partial hydrolysis of the added maltodextrins during processing.…”
Section: Resultssupporting
confidence: 67%
“…The galactose content was higher than those found by Morales et al (2004) and similar to those obtained by Troyano, Villamiel, Olano, Sanz, and Martinez-Castro (1996) in commercial sterilized milks. Myo-inositol, a polyalcohol that may play a significant role in the prevention of bronchopulmonary dysplasia and retinopathy in premature infants (Hallman, Saugstad, Porreco, Epstein, & Gluck, 1985), was present in all IFs at concentrations significantly higher than those reported for Spanish commercial milks (Troyano et al, 1996), but similar to the found by Woollard, Macfadzean, Indyk, McMahon, and Christiansen (2014). As expected, with the exception of the lactose-free IFs, lactose was the main carbohydrate in all studied products, with amounts varying between 19.2 and 70.1 g/100 g. Maltose was found in most of the analysed IFs in a range from 0.2 to 7 g/100 g. This compound is usually not added as ingredient in IFs and its presence may be related to the partial hydrolysis of the added maltodextrins during processing.…”
Section: Resultssupporting
confidence: 67%
“…Free inositols occur naturally in the environment as a bioactive component of living cells. Milk is a significant source of myo-inositol and for its role in neonatal nutrition, this polyol is often added to infant formulas to prevent a potential deficiency during early neonatal growth stage [38]. As well as urea, myo-inositol is osmolyte and the lower level of this polyol in GS2 can counterbalance their high urea content.…”
Section: Discussionmentioning
confidence: 99%
“…Myo-inositol, as a conditionally essential nutrient, has been shown to have chemopreventive and chemotherapeutic properties in cancer, cataracts, neuropathy, and nephropathy (Grases et al, 2002;Rizvi et al, 2006;Liu et al, 2009;Schlemmer et al, 2009;Corrado et al, 2011). Additionally, myo-inositol is a compound necessary for babies, and when this substance cannot be administered through breast milk, it must be sup- plied in the diet by inositol-enriched milk or formula (Hallman et al, 1987;Flores et al, 2011;Woollard et al, 2014;Indyk et al, 2016). In this study, myo-inositol was also identified in donkey milk.…”
Section: Discussionmentioning
confidence: 62%